Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial.

医学 减肥 耐受性 临床试验 随机对照试验 人口 肥胖 内科学 气球 外科 不利影响
作者
Barham K Abu Dayyeh,Daniel B Maselli,Babusai Rapaka,Thomas Lavin,Mark Noar,Hisham Hussan,Christopher G Chapman,Violeta Popov,Pichamol Jirapinyo,Andres Acosta,Eric J Vargas,Andrew C Storm,Fateh Bazerbachi,Marvin Ryou,Matthew French,Sabrena Noria,Daniel Molina,Christopher C Thompson
出处
期刊:The Lancet [Elsevier BV]
卷期号:398 (10315): 1965-1973 被引量:7
标识
DOI:10.1016/s0140-6736(21)02394-1
摘要

Intragastric balloons are anatomy-preserving, minimally invasive obesity therapies. Enhanced tolerance and durability could help broaden clinical adoption. We investigated the safety and efficacy of an adjustable intragastric balloon (aIGB) in adults with obesity.In this prospective, multicentre, open-label, randomised clinical trial done at seven US sites, adults aged 22-65 years with obesity were randomly assigned (2:1) to aIGB with lifestyle intervention or lifestyle intervention alone (control) for 32 weeks. Balloon volume could be increased to facilitate weight loss or decreased for tolerability. Coprimary endpoints included mean percentage total bodyweight loss and responder rate (≥5% total bodyweight loss) at 32 weeks. We used a multiple imputed intention-to-treat population analysis. This study was registered with ClinicalTrials.gov, NCT02812160.Between Aug 9, 2016, and Dec 7, 2018, we randomly assigned 288 patients to aIGB (n=187 [65%]) or control (n=101 [35%]) groups. Mean total bodyweight loss at 32 weeks was 15·0% (95% CI 13·9-16·1) in the aIGB group versus 3·3% (2·0-4·6) in the control group (p<0·0001). Clinical response was observed in 171 (92%) patients in the aIGB group. Adjustments to the aIGB occurred in 145 (80%) patients for weight loss plateau or intolerance. Upward volume adjustment facilitated an additional mean 5·2% (4·5-5·8) total bodyweight loss. Downward volume adjustment allowed 21 (75%) patients in the aIGB group to complete the full duration of therapy. Intolerance caused early removal of the device in 31 (17%) patients. No micronutrient deficiencies were observed in the aIGB cohort. Device-related serious adverse events were observed in seven (4%) patients, without any deaths.When aIGB was combined with lifestyle modification, significant weight loss was achieved and maintained for 6 months following removal. Balloon volume adjustability permitted individualised therapy, maximising weight loss and tolerance.Spatz Medical.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后应助帅气的猫采纳,获得10
1秒前
1秒前
外向烤鸡完成签到,获得积分10
2秒前
2秒前
搜集达人应助等待的士晋采纳,获得10
2秒前
2秒前
兴奋赛君完成签到,获得积分10
3秒前
zhy完成签到,获得积分10
3秒前
企鹅大王完成签到,获得积分10
4秒前
酷酷海白发布了新的文献求助10
4秒前
淡墨发布了新的文献求助10
4秒前
怎样不怀念呢完成签到,获得积分20
5秒前
晓畅发布了新的文献求助10
5秒前
欧阳振应助zcl采纳,获得10
5秒前
zhouz发布了新的文献求助10
6秒前
自建发布了新的文献求助10
6秒前
yyxx发布了新的文献求助10
6秒前
xxx发布了新的文献求助10
7秒前
7秒前
LINCHEN发布了新的文献求助20
7秒前
清脆泥猴桃完成签到,获得积分10
8秒前
9秒前
9秒前
CipherSage应助武原龙采纳,获得10
9秒前
ZhihaoYang完成签到,获得积分10
9秒前
10秒前
YYQ完成签到,获得积分20
11秒前
12秒前
SYLH应助FLZLC采纳,获得10
13秒前
淡墨完成签到,获得积分10
13秒前
1111应助大可采纳,获得10
14秒前
所所应助痕迹采纳,获得10
14秒前
yyxx完成签到,获得积分10
14秒前
15秒前
端庄的蜡烛完成签到,获得积分20
15秒前
15秒前
15秒前
xxx完成签到,获得积分10
15秒前
YYQ发布了新的文献求助30
15秒前
大尾猫发布了新的文献求助10
16秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Christian Women in Chinese Society: The Anglican Story 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3961496
求助须知:如何正确求助?哪些是违规求助? 3507837
关于积分的说明 11138394
捐赠科研通 3240311
什么是DOI,文献DOI怎么找? 1790903
邀请新用户注册赠送积分活动 872636
科研通“疑难数据库(出版商)”最低求助积分说明 803288